Chester County News and Community Website
DOYLESTOWN, PA — Aprea Therapeutics (Nasdaq: APRE) has announced a key update in its ongoing Phase 1/2a ABOYA-119 clinical trial for ATRN-119, aimed at treating advanced solid tumors with DNA damage …
Aprea Therapeutics Updates ABOYA-119 Trial with Twice Daily Dosing Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. has announced a new patent application for istaroxime derivatives, aimed at preventing or reducing the risk of acute myocardial arrhythmia. The filing builds on encouraging …
Windtree Therapeutics Files Patent for Istaroxime Derivatives to Combat Acute Myocardial Arrhythmia Read More
NEWTOWN, PA and NEWRY, N. Ireland — EPAM Systems, Inc. (NYSE: EPAM) has finalized its acquisition of First Derivative, a consulting and managed services firm specializing in capital markets. With over …
EPAM Systems Completes Acquisition of First Derivative to Enhance Financial Services Offerings Read More
LEVITTOWN, PA — Fire Truck Center has announced the launch of custom-built brush trucks designed to meet the demanding needs of fire departments tackling wildland and rural fires. These vehicles …
Fire Truck Center Debuts Custom Brush Trucks for Wildland Firefighting Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has partnered with New Growth Advisors (NGA), a prominent life sciences consulting firm, to explore strategic options for its cardiovascular portfolio. The …
Windtree Therapeutics Engages New Growth Advisors to Explore Strategic Opportunities Read More
YARDLEY, PA — Optinose (NASDAQ: OPTN) has announced that its management team will deliver a company overview and business update at the Piper Sandler 36th Annual Healthcare Conference on December …
Optinose to Present at Piper Sandler Healthcare Conference Read More
LANGHORNE, PA — Amplity Health shared valuable findings from its latest study on GLP-1 receptor agonist (GLP-1 RA) usage patterns during the ISPOR Europe 2024 conference. The research, based on …
Amplity Health Reveals Key Insights on GLP-1 Receptor Agonist Usage at ISPOR Europe 2024 Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced its financial results for the third quarter ending September 30, 2024, alongside significant business updates. The company achieved progress in …
Windtree Therapeutics Reports Q3 Results and Highlights Key Business Achievements Read More
SOUTHAMPTON, PA — Environmental Tectonics Corporation (OTC Pink: ETCC) has finalized a $4 million sale and leaseback transaction involving demonstration equipment at its Southampton, Pennsylvania location. The deal, which closed …
Environmental Tectonics Corporation Completes $4 Million Sale and Leaseback Agreement Read More
QUAKERTOWN, PA — During a regular meeting, the Board of Directors of QNB Corp. (OTC Bulletin Board: QNBC), the parent company of QNB Bank, announced a quarterly cash dividend of …
QNB Corp Declares $0.37 Quarterly Dividend for Shareholders! Read More